Axel Bolte
2022
In 2022, Axel Bolte earned a total compensation of $2.2M as Former President and Chief Executive Officer at Inozyme Pharma, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $306,087 |
|---|---|
| Option Awards | $1,176,518 |
| Salary | $559,676 |
| Other | $169,094 |
| Total | $2,211,375 |
Bolte received $1.2M in option awards, accounting for 53% of the total pay in 2022.
Bolte also received $306.1K in non-equity incentive plan, $559.7K in salary and $169.1K in other compensation.
Rankings
In 2022, Axel Bolte's compensation ranked 1,627th out of 5,756 executives tracked by ExecPay. In other words, Bolte earned more than 71.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,627 out of 5,756 | 72nd |
Division Manufacturing | 836 out of 3,133 | 73rd |
Major group Chemicals And Allied Products | 329 out of 1,419 | 77th |
Industry group Drugs | 305 out of 1,320 | 77th |
Industry Pharmaceutical Preparations | 219 out of 966 | 77th |
Source: SEC filing on April 27, 2023.
Bolte's colleagues
We found two more compensation records of executives who worked with Axel Bolte at Inozyme Pharma in 2022.